HealthCare Global Enterprises Limited has successfully completed the allotment of equity shares under its rights issue, marking a significant milestone in the company's capital raising initiative. The Rights Issue Committee meeting held on March 27, 2026, approved the allotment of 82,94,566 equity shares to eligible shareholders and renouncees.

Rights Issue Details

The rights issue was conducted with specific terms that provided existing shareholders the opportunity to subscribe to additional shares. The issue opened on March 11, 2026, and closed on March 25, 2026, giving eligible shareholders a two-week window to participate. The record date for determining eligible shareholders was set as March 02, 2026.

Capital Structure Impact

The successful completion of the rights issue has resulted in a substantial increase in the company's paid-up equity share capital. The allotment has enhanced the company's capital base from ₹141,00,76,370 to ₹149,30,22,030, providing additional financial resources for its operations and growth initiatives.

Committee Meeting and Approval Process

The Rights Issue Committee meeting commenced at 8:10 p.m. and concluded at 10:00 p.m. on March 27, 2026. The committee worked in consultation with Kfin Technologies Limited, serving as the Registrar to the Issue, and received approval from the designated stock exchange, National Stock Exchange of India Limited, for the finalization of the basis of allotment.

Regulatory Compliance

The allotment process was conducted in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has fulfilled all regulatory requirements and disclosed the necessary information as prescribed under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

The rights issue represents a strategic move by HealthCare Global Enterprises to strengthen its financial position and support future business objectives. The successful completion demonstrates investor confidence in the company's prospects and management's ability to execute capital raising initiatives effectively.

Healthcare Global Enterprises Limited has completed the winding up of its wholly owned indirect subsidiary Healthcare Global (Tanzania) Private Limited, marking the end of its corporate presence in Tanzania. The company received formal notification of the winding up on March 26, 2026, though the effective date of closure was March 02, 2026.

Subsidiary Details and Operations

Healthcare Global (Tanzania) Private Limited was a non-operating entity incorporated in Tanzania. The subsidiary had remained inactive throughout its existence, contributing nothing to the parent company's financial performance.

Financial Impact Assessment

The closure of HCG Tanzania will have no material impact on HealthCare Global Enterprises' financial position. During the last financial year, the subsidiary made no contribution to the parent company's operations or financial metrics.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has fulfilled all disclosure requirements as mandated by SEBI circulars SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

The winding up process did not involve any sale transactions, related party dealings, or schemes of arrangement. As a non-operational indirect subsidiary, the closure represents a routine corporate housekeeping measure rather than a strategic business decision with operational implications.